Skip to main content

Clinical

Todd Williamson, MsC; Rajesh Kamalakar, MS; Augustina Ogbonnaya, MPH; Erin A. Zagadailov, PharmD, MS; Michael Eaddy, PharmD, PhD; Charlie Kreilick, MBA
The Challenge of Rosacea Treatment
Atheer A. Kaddis, PharmD
Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni, MPH; Kui Zhang, MD; Catherine Datto, MD, MS
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Jack E. Fincham, PhD, RPh
Jill R. Davis, MS; Bingcao Wu, MS; David M. Kern, PhD; Ozgur Tunceli, PhD; Kathleen M. Fox, PhD; John Horton, MS; Randall F. Legg, PharmD, MBA; Frank Trudo, MD, MBA
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD
Michael F. Murphy, MD, PhD
The Challenge of Managing Specialty Drugs for Psoriasis
Using Statin Therapy to Reduce Atherosclerotic Cardiovascular Disease Risk
Important Insights from Real-World Treatment Patterns and Outcomes for Varicose Veins Management
Provider and Payer Collaboration Needed to Ensure Adherence to Recommended Eye Examinations in Patients with Diabetes
Patient Characteristics, Adherence, and a Metric of Organizational Performance in Behavioral Health
Evaluating the True Value of High-Cost Therapies for Hepatitis C Infection
Implications of Big Data Analysis in the Real-World Setting: The Case of Overactive Bladder Treatment
Page 6 of 15
Results 51 - 60 of 146